No Data
No Data
Sanyo Kasei --- physician-led clinical trial confirms safety of silk elastin against meniscus injury
Sanyo Chemical Industries (4471) announced on the 21st that it conducted a doctor-led clinical trial of a new treatment method using silk elastin for patients with meniscus injury (meniscus suture) at Hiroshima University Hospital, and its safety was confirmed. In joint research between the company and Hiroshima University Graduate School of Biomedical Sciences Orthopedic Surgery (hereafter, Hiroshima University), it was discovered that silk elastin has the effect of promoting meniscus regeneration. Physicians who aim to confirm the safety of silk elastin based on these results
Convertible Stock List (Part 1) [Parabolic Signal Convertible Stock List]
○List of trading stocks market code stock name closing price SAR Tokyo Stock Exchange Prime <3107> Daiwabo HD 2719 2550 <3132> Macnica HD 6792 6360 <3401> Teijin 1550 1389 <4062> Ibiden 5790 5134 <4471> Sanyo Kasei 4090 3915 <4503
3 points to pay attention to in the front market ~ From wait-and-see and buybacks to solid price movements in high-tech ~
I would like to pay attention to the following 3 points in the pre-market transaction on the 22nd. ■ From wait-and-see buybacks to solid price movements ■ No financial results announcements ■ Notable materials from the front floor: Horiba Seisakusho expands car-related bases in England and introduces the latest equipment for crash tests ■ High-tech is likely to continue with a strong sense of stalemate in the Japanese stock market on the 22nd from wait-and-see buybacks to solid price movements. In the US market on the 21st, the NY Dow rose 66 dollars and the NASDAQ was 37 points higher. US Federal Reserve (Fed)
Horiba Seisakusho, ShinMaywa Industries, etc.
*Horiba Seisakusho <6856> expands car-related base in English and introduces the latest equipment for crash tests (Nikkan Kogyo side 1) - ○*ShinMaywa Kogyo <7224> garbage truck operation support, recip and system development (Nikkan Kogyo side 1) - ○*Panasonic HD <6752> domestic production of in-vehicle batteries 2.5 times over 30 years, promoting labor saving (Nikkan Kogyo page 3) - ○*Yamato HD <9064> supports joint transportation and delivery (Nikkan Kogyo 3 sides)) -○*Aichi Steel <5482 >Lee for power cards
Sanyo Chemical --- even though sales declined for the fiscal year ending March 24, the next fiscal year will promote improved profits and sales expansion of high value-added products due to business structural reforms
Sanyo Chemical Industries (4471) announced consolidated financial results for the fiscal year ending 2024/3 on the 14th. Net sales decreased 8.8% from the previous fiscal year to 159.51 billion yen, operating profit decreased 39.8% to 4.886 billion yen, ordinary profit fell 17.5% to 8.186 billion yen, and net loss attributable to parent company shareholders was 8.501 billion yen (profit of 5.684 billion yen for the previous fiscal year). Sales in the lifestyle and health industry-related fields were 45.895 billion yen, down 19.6% from the same period last year, and operating losses were 1,421 billion yen (0 for the same period last year
Sanyo Kasei --- Starts selling “EXORPTION (R),” an extracellular vesicle (EV) purification kit such as exosomes
Sanyo Chemical Industries (4471) announced on the 13th that it will start selling “EXORPTION (R).” “EXORPTION (R)” is a purification kit that can recover extracellular vesicles (EVs) such as exosomes in a short time with high purity and high yield with simple operation. Sales of this kit began in 2024/5 through Cosmo Bio <3386> and Takara Bio <4974>. “EXORPTION (R)” is a special hydrogel bee that absorbs body fluids
No Data